uu.seUppsala universitets publikasjoner
Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
GH deficiency during the transition period: clinical characteristics before and after GH replacement therapy in two different subgroups of patients
Endocrinology Unit, Department of Medicine, Hospital T Alvarez, Buenos Aires, Argentina.
Uppsala universitet, Medicinska och farmaceutiska vetenskapsområdet, Medicinska fakulteten, Institutionen för kvinnors och barns hälsa. (Barnendokrinologisk forskning/Gustafsson)
Department of Pediatrics, Federal University of Paraná, Curitiba, Brazil.
Vise andre og tillknytning
2012 (engelsk)Inngår i: Journal of Pediatric Endocrinology & Metabolism (JPEM), ISSN 0334-018X, E-ISSN 2191-0251, Vol. 25, nr 1-2, s. 97-105Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

Objective:

To study two subsets of patients with GH deficiency (GHD) during the transition period: childhood onset GHD (CO-GHD) and patients who develop GHD during the transition phase (TO-GHD) before and after GH replacement.

Patients and measurements:

In 1340 GHD subjects from KIMS (Pfizer International Metabolic Database), CO (n=586) or TO (n=754), background characteristics, anthropometric measurements, IGF-1, lipids and quality of life (QoL) were evaluated at baseline and after 3 years of GH replacement.

Results:

Both groups responded similarly to GH treatment. Changes of clinical outcomes were mainly determined by their value at baseline. Onset of the disease in childhood or transition period did not appear to be a significant predictor of response in any of the clinical outcomes.

Conclusions:

Age at GHD diagnosis was a significant predictor for many outcomes at baseline, but disease onset did not appear as an independent predictor concerning changes after 3 years of GH treatment. The results suggest that GH replacement during the transition period should be considered independently of the onset of the deficiency.

sted, utgiver, år, opplag, sider
2012. Vol. 25, nr 1-2, s. 97-105
HSV kategori
Identifikatorer
URN: urn:nbn:se:uu:diva-163759DOI: 10.1515/JPEM.2011.349ISI: 000305708000014OAI: oai:DiVA.org:uu-163759DiVA, id: diva2:464773
Tilgjengelig fra: 2011-12-14 Laget: 2011-12-14 Sist oppdatert: 2017-12-08bibliografisk kontrollert

Open Access i DiVA

Fulltekst mangler i DiVA

Andre lenker

Forlagets fulltekst

Personposter BETA

Jonsson, Björn

Søk i DiVA

Av forfatter/redaktør
Jonsson, Björn
Av organisasjonen
I samme tidsskrift
Journal of Pediatric Endocrinology & Metabolism (JPEM)

Søk utenfor DiVA

GoogleGoogle Scholar

doi
urn-nbn

Altmetric

doi
urn-nbn
Totalt: 691 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf